Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Objective response to systemic therapy linked to overall survival in unresectable HCC
23 Jan 2023
bởiStephen Padilla
Objective response to first-line systemic therapy with lenvatinib or sorafenib independently predicts overall survival (OS) in individuals with unresectable hepatocellular carcinoma (HCC), as shown by the subanalysis of the REFLECT study.
Objective response to systemic therapy linked to overall survival in unresectable HCC
23 Jan 2023Multiple moles, genetic predisposition up risk of second primary melanomas
22 Jan 2023
Individuals with multiple nevi and high genetic predisposition to melanoma appear to have the highest risks of developing second primary melanomas, according to a study.